Are you or your loved ones suffering from endometrial cancer recurrent?

You may be eligible to participate in a endometrial cancer recurrent clinical trial.

Are you or your loved ones suffering from endometrial cancer recurrent? You may be eligible to participate in a endometrial cancer recurrent clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Recruiting for this study? Get access to patient recruitment tools.
Type II Endometrial Cancer in New Brunswick NJ
NCT03485729 | Phase 2 | Interventional
Oncoceutics Inc
Sponsored by
Oncoceutics Inc

Are you or your loved ones suffering from endometrial cancer recurrent?

You may be eligible to participate in a endometrial cancer recurrent clinical trial.

Are you or your loved ones suffering from endometrial cancer recurrent? You may be eligible to participate in a endometrial cancer recurrent clinical trial.

Recruiting

Female

18 +

years old

This study is looking to recruit 30 Participants

This is a a Simon's two-stage, non-randomized, open label, 2-arm Phase II trial of ONC201 in women with metastatic or recurrent Type II endometrial cancer who failed at least 1 prior chemotherapy regimen.

Where you'll go

Selected location

Available locations
UNC Lineberger Comprehensive Cancer Center

UNC Lineberger Comprehensive Cancer Center

Recruiting 450 West Drive, Chapel Hill, NC, USA 27599

Fox Chase Cancer Center

Fox Chase Cancer Center

Recruiting 333 Cottman Avenue, Philadelphia, PA, USA 19111

Interested in participating?
Selected location

Rutgers The State University of New Jersey

New Brunswick, NJ, USA 08903

Lorna Rodriguez, MD PhD 732-235-2465
rodriglo@cinj.rutgers.edu


The information you provide is confidential and is never sold or shared with outside vendors. By clicking the button, you agree to the PatientWing's Terms and Privacy Policy.